Mucosal immunity in the lung and upper airway

Citation
Jm. Kyd et al., Mucosal immunity in the lung and upper airway, VACCINE, 19(17-19), 2001, pp. 2527-2533
Citations number
61
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VACCINE
ISSN journal
0264410X → ACNP
Volume
19
Issue
17-19
Year of publication
2001
Pages
2527 - 2533
Database
ISI
SICI code
0264-410X(20010321)19:17-19<2527:MIITLA>2.0.ZU;2-4
Abstract
The mucosal surfaces of the lungs and upper airways are common sites for in fection. Extensive studies of the mechanisms associated with immune respons es in the respiratory tract have found that understanding the: system is ch allenging and involves many complex interactions to prevent and eliminate i nfection. Immune protection against diseases transmitted through the respir atory tract requires an understanding of the important aspects associated w ith beneficial, detrimental or ineffective immune responses. Two critical a spects of an immune response against a pathogen are that of the inductive s tage, either induced by vaccination or primary infection. and the effector stage, the ability to recognise, respond to and eliminate the infection wit hout detriment to the host. An immunisation strategy must not only have a m easure of the induced antigen specific response. but this response must als o be protective. (C) 2001 Elsevier Science Ltd. All rights reserved.